Nebulizer Market To Generate Revenue Worth $1,696.7 Million by 2030

The nebulizer market generated revenue of USD 1,050.2 million in 2023, and it is expected to reach USD 1,696.7 million by 2030, advancing a growth rate of 7.4% during 2024–2030. This can be ascribed to the increasing air pollution levels, the rising health expenditure, the surging respiratory diseases, the growing geriatric population, the increasing usage of cigarettes, and the easy availability of portable devices of key players.

• A nebulizer is a device that allows patients with respiratory disorders to deliver medications directly to their lungs.
• These devices typically consist of a motor, mouthpiece, cup, and hose, and use oxygen, compressed air, or ultrasound to break liquid medication into aerosols.
• Doctors prescribe them to patients who cannot breathe deeply when using an inhaler.
• Nebulizers are primarily used to treat severe respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis.

Jet Nebulizer Accounts for the Largest Revenue Share

The jet nebulizer category holds the largest market share. The cost-effectiveness and ease of use of nebulizers are the main factors driving the growth of the market in this category.

• Moreover, this is due to a high gas flow rate through this nebulizer, evaporation of solvents during nebulization, and reduction in the delivered volume with minimal patient cooperation. In addition, a jet nebulizer can deliver formulations, that pressurized metered dose inhalers (pMDIs) and dry powder inhalers (DPIs) cannot.

The market is divided based on modality into tabletop and portable categories. The operational advantages of tabletop nebulizer devices and their cost efficiency are some of the key factors behind its revenue growth.

• Moreover, the presence of large companies with a wide product line of tabletop nebulizers also contributes to the expansion of the market in this category.

Mesh nebulizers offer constant and improved aerosol generation efficiency, a predominantly fine particle fraction reaching the peripheral lungs, minimal residual volume, and the ability to nebulize a small amount of medication. Thus, these factors drive the market growth in this category.

• Additionally, the pore size, aerosol chamber and reservoir, and mesh nebulizer output rate can be adjusted for different drugs to optimize aerosol delivery to the patient, resulting in efficiency, convenience, and higher patient doses.

The home care category is expected to witness the fastest growth in the coming years, due to the increasing number of portable product launches and the relative affordability of these products.

• The use of portable equipment reduces waste, facilitates handling during inhalation therapy, and reduces patient effort.
• The high cost of hospital visits and stays has increased patient preferences for home care, which is one of the major factors driving the market growth in this category.

APAC Market To Grow at the Highest Rate

The Asia-Pacific market will grow at the highest rate during the forecast period, due to the increasing prevalence of chronic respiratory diseases, the rising number of medical device companies, and surging investment in various R&D initiatives for innovative product development in the region.

• Moreover, the growing geriatric population, the rising awareness of such devices, the surging government support and favorable tax policies, and the increasing investment and cooperation by large foreign companies are driving the growth of the regional market.

Some of the key players operating in the nebulizer market include Beurer GmbH, GF Health Products Inc., Pari GmbH, Allied Healthcare Products Inc., Aerogen Ltd., Briggs Healthcare, OMRON Corporation, Rossmax Swiss GmbH, Vectura Group plc, Becton, Dickinson and Company, General Electric Company, Agilent Technologies Inc., Medline Industries Inc., and Koninklijke Philips N.V.